US Pharma and Biotech Summit

May 15, 2025

Innovating and investing in a new era for American healthcare

In-Person & Digital | Convene One Liberty Plaza, New York | #FTPharma

Video on demand available now

The US biopharmaceutical industry faces relentless disruption. America leads the world in high-risk drug development, but how will President Trump's health policy picks stamp their authority? Advances in AI are accelerating innovation, but when will they generate returns and how will they transform workforces?

Organized by FT Live in collaboration with Endpoints News, the event brought together top executives, investors and experts to share powerful insights into the future of life sciences in America and worldwide.

In Collaboration With

Global drug discovery partner

Strategic Sponsor

Lead Sponsor

Associate Sponsor

Networking Sponsor

Explore the 2025 attendee list

2025 ATTENDEE LIST

Confirmed speakers include:

Joe Betts-LaCroix

CEO

Retro Biosciences

Christopher Boerner

Board Chair and CEO

Bristol Myers Squibb

Priya Singhal

Executive Vice President and Head of Development

Biogen

Sebastian Guth

President, Bayer US, Chief Operating Officer

Bayer Pharmaceuticals

Faisal M. Khan

Corporate Vice President, Artificial Intelligence and Analytics

Novo Nordisk

Hesham Abdullah

Senior Vice President, Global Head Oncology, Research and Development

GSK

Amber Salzman

CEO

Epicrispr Biotechnologies

Laura Steele

Senior Vice President, US Neuroscience

Lilly

"This was my first time attending a FT Live Event and I believe it was really well done."

- Head of Life Sciences, Novo Nordisk

300+

Attendees

40+

Speakers & Moderators

250+

Companies represented

20+

Countries

Key themes and discussions

Trump 2.0 and biopharma
How could FDA policy and industry regulation change?

Dealmaking environment
Is dealmaking activity set to surge with rate cuts?

Clinical trial agility
How are industry-wide shifts in R&D affecting pipeline success rates?

Artificial intelligence in life sciences
Where is AI delivering return on investment for biopharma companies?

Advanced therapies
Where is the innovation in scaling cell and gene therapies?

Biopharma workforce transformation
How do shifting priorities affect hiring and where are the career opportunities?

view agenda

Supporting Partners

Supporting Partner

The power of in-person networking

Engage with senior executives from prominent life sciences companies, CROs and healthcare providers
75% of attendees in 2023 had a job title of 'Head of' or above, so true decision-makers will be on site
Schedule 1-to-1 meetings with leaders in the online event community
Establish new relationships and strengthen ties at our evening drinks reception
FT editors and other global press outlets will be there

FIND OUT MORE